Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS)

Compare
26.27
-0.24
(-0.91%)
At close: 3:00:01 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Youzhang Xia GM & Director -- -- 1979
Mr. Tao Mao Finance Director & Accounting Supervisor -- -- 1975
Mr. Ping An Liu Deputy GM & Director -- -- 1987
Ms. Qian Ma Deputy GM & Secretary to the Board of Directors -- -- 1982

Mayinglong Pharmaceutical Group Co., Ltd.

No. 100, Zhoujiawan
Nanhu Lake Wuchang District
Wuhan, 430064
China
86 27 8738 9583 https://www.mayinglong.cn
Sector: 
Healthcare

Description

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical products comprising anorectal postoperative care, daily electronic auxiliary products, eye device care, disinfection and sterilization, etc. In addition, the company is involved in the development, production, and sale of pharmaceutical products; retail and wholesale of medical devices and drugs; provision of hospital medical and management service; and hospital operations. It sells its products through online stores. Mayinglong Pharmaceutical Group Co., Ltd., was founded in 1582 and is headquartered in Wuhan, China.

Corporate Governance

Mayinglong Pharmaceutical Group Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 26, 2024 at 12:00 AM UTC

Ex-Dividend Date